MIRASOL RESOURCES LTD (MRZ.CA) Fundamental Analysis & Valuation

TSX-V:MRZ • CA6046801081

Current stock price

0.51 CAD
+0.02 (+4.08%)
Last:

This MRZ.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MRZ.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MRZ has reported negative net income.
  • In the past year MRZ has reported a negative cash flow from operations.
  • In the past 5 years MRZ always reported negative net income.
  • MRZ had a negative operating cash flow in each of the past 5 years.
MRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFMRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • MRZ has a Return On Assets of -185.85%. This is amonst the worse of the industry: MRZ underperforms 81.43% of its industry peers.
Industry RankSector Rank
ROA -185.85%
ROE N/A
ROIC N/A
ROA(3y)-200.17%
ROA(5y)-140.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRZ.CA Yearly ROA, ROE, ROICMRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K

1.3 Margins

  • MRZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRZ.CA Yearly Profit, Operating, Gross MarginsMRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

0

2. MRZ.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for MRZ has been increased compared to 1 year ago.
  • Compared to 5 years ago, MRZ has more shares outstanding
  • Compared to 1 year ago, MRZ has a worse debt to assets ratio.
MRZ.CA Yearly Shares OutstandingMRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MRZ.CA Yearly Total Debt VS Total AssetsMRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • MRZ has an Altman-Z score of -31.94. This is a bad value and indicates that MRZ is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -31.94, MRZ is not doing good in the industry: 78.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -31.94
ROIC/WACCN/A
WACCN/A
MRZ.CA Yearly LT Debt VS Equity VS FCFMRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that MRZ may have some problems paying its short term obligations.
  • MRZ has a worse Current ratio (0.51) than 71.89% of its industry peers.
  • MRZ has a Quick Ratio of 0.51. This is a bad value and indicates that MRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRZ has a worse Quick ratio (0.51) than 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
MRZ.CA Yearly Current Assets VS Current LiabilitesMRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

0

3. MRZ.CA Growth Analysis

3.1 Past

  • MRZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.85%, which is quite impressive.
EPS 1Y (TTM)38.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. MRZ.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MRZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRZ.CA Price Earnings VS Forward Price EarningsMRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRZ.CA Per share dataMRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. MRZ.CA Dividend Analysis

5.1 Amount

  • No dividends for MRZ!.
Industry RankSector Rank
Dividend Yield 0%

MRZ.CA Fundamentals: All Metrics, Ratios and Statistics

MIRASOL RESOURCES LTD

TSX-V:MRZ (4/17/2026, 7:00:00 PM)

0.51

+0.02 (+4.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-26
Earnings (Next)N/A
Inst Owners11.3%
Inst Owner ChangeN/A
Ins Owners43.61%
Ins Owner ChangeN/A
Market Cap45.19M
Revenue(TTM)N/A
Net Income(TTM)-6.22M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -185.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-200.17%
ROA(5y)-140.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z -31.94
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)127.61%
Cap/Depr(5y)113.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.84%
OCF growth 3YN/A
OCF growth 5YN/A

MIRASOL RESOURCES LTD / MRZ.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MIRASOL RESOURCES LTD (MRZ.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to MRZ.CA.


What is the valuation status of MIRASOL RESOURCES LTD (MRZ.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to MIRASOL RESOURCES LTD (MRZ.CA). This can be considered as Overvalued.


Can you provide the profitability details for MIRASOL RESOURCES LTD?

MIRASOL RESOURCES LTD (MRZ.CA) has a profitability rating of 0 / 10.


How financially healthy is MIRASOL RESOURCES LTD?

The financial health rating of MIRASOL RESOURCES LTD (MRZ.CA) is 0 / 10.